Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.
Times cited: 196
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.
New England Journal of Medicine.
Times cited: 1142